Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions in Gout: A Pilot Study
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Bone disorders; Gout
- Focus Proof of concept; Therapeutic Use
- 06 Apr 2017 Status changed from not yet recruiting to recruiting.
- 27 Dec 2016 Planned initiation date changed from 1 Dec 2016 to 1 Jan 2017.
- 02 Nov 2016 Planned initiation date changed from 1 Oct 2016 to 1 Dec 2016.